Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (433)

Latest Posts

About This Stock More About This Stock
Gilead To Invest $109M In Goldfinch Bio For Kidney Drug Collaboration
Article By: Benzinga
Wednesday, May 8, 2019 3:30 PM EDT
Gilead Sciences, Inc., which recently suffered setbacks in non-alcoholic steatohepatitis drug development, is looking elsewhere to develop its product portfolio.
In this article: GILD Also: IBB
Read
Weighing The Week Ahead: Should Investors Fear A Market Top?
Article By: Jeff Miller
Sunday, May 5, 2019 11:37 AM EDT
Investors will never have more current information on the economy, the Fed, corporate earnings and risks than they do now. It is difficult to guess what the punditry will do when given an open slate. We should be asking: Should we fear a market top?
In this article: APC, MRNA, FB, GOOGL, AMZN, COST, GILD, BURL, GLD, INTC, TSLA
Read
Wall Street's Top Stories At Midday, May 1st
Article By: The Fly
Wednesday, May 1, 2019 1:35 PM EDT
Stocks rise after Apple earnings beat as investors await the Fed.
In this article: CVS, HD, NUS, PCRX, AAPL, GILD, GRMN, ENPH, HRTX, TWLO, NBRV
Read
Weighing The Week Ahead: What Will Q1 Earnings Reveal About Economic Strength?
Article By: Jeff Miller
Sunday, April 14, 2019 11:09 AM EDT
The economic calendar is normal and includes some important reports. The data will be overshadowed by Q1 earnings reports. With opinion sharply divided on future economic prospects, many will want to know how companies are doing.
In this article: FAST, GILD, TTD
Read
Stocks Are Pointing To A Higher Opening On April 10
Article By: Michael J. Kramer
Wednesday, April 10, 2019 8:50 AM EDT
S&P 500 futures are pointing to a higher opening with resistance taking shape around 2,891 if we can clear that resistance level, the index finally has a path towards 2,915.
In this article: DIS, GILD, SPY, AMD, AAPL
Read

PARTNER HEADLINES

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments